Y-mAbs Therapeutics (YMAB) Insider Trading & Ownership $8.51 -0.01 (-0.12%) Closing price 04:00 PM EasternExtended Trading$8.52 +0.01 (+0.06%) As of 07:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Y-mAbs Therapeutics (NASDAQ:YMAB) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage19.70%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)3Amount OfInsider Selling(Last 12 Months)$1.42M Get YMAB Insider Trade Alerts Want to know when executives and insiders are buying or selling Y-mAbs Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address YMAB Insider Buying and Selling by Quarter Y-mAbs Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/7/2025Michael J RossiCEOSell3,917$5.20$20,368.40 3/7/2025Thomas GadInsiderSell10,810$5.23$56,536.30 9/16/2024Thomas GadInsiderSell30,000$12.97$389,100.00 9/13/2024Thomas GadInsiderSell65,000$13.47$875,550.00 8/26/2024Joris WilmsCOOSell5,000$14.69$73,450.00 (Data available from 1/1/2013 forward) YMAB Insider Trading Activity - Frequently Asked Questions Who is on Y-mAbs Therapeutics' Insider Roster? The list of insiders at Y-mAbs Therapeutics includes Biotech Aps Wg, Bo Kruse, Gerard Ber, Johan Wedell-Wedellsborg, Joris Wilms, Michael J Rossi, Thomas Gad, and Vignesh Rajah. Learn more on insiders at YMAB. What percentage of Y-mAbs Therapeutics stock is owned by insiders? 19.70% of Y-mAbs Therapeutics stock is owned by insiders. Learn more on YMAB's insider holdings. Which Y-mAbs Therapeutics insiders have been buying company stock? The following insiders have purchased YMAB shares in the last 24 months: Biotech Aps Wg ($1,070,726.02), and Johan Wedell-Wedellsborg ($343,212.84). How much insider buying is happening at Y-mAbs Therapeutics? Insiders have purchased a total of 223,399 YMAB shares in the last 24 months for a total of $1,413,938.86 bought. Which Y-mAbs Therapeutics insiders have been selling company stock? The following insiders have sold YMAB shares in the last 24 months: Bo Kruse ($378,647.97), Gerard Ber ($8,664.00), Joris Wilms ($73,450.00), Michael J Rossi ($20,368.40), Thomas Gad ($3,194,799.30), and Vignesh Rajah ($28,282.83). How much insider selling is happening at Y-mAbs Therapeutics? Insiders have sold a total of 390,882 Y-mAbs Therapeutics shares in the last 24 months for a total of $3,704,212.50 sold. Y-mAbs Therapeutics Key ExecutivesMr. Thomas Gad (Age 53)Founder, Chief Business Officer & Vice Chairman Compensation: $1.05M1 recent tradesMr. Bo Kruse (Age 51)Executive VP, Secretary, Treasurer & CFO Compensation: $685.02kMs. Susan Smith (Age 53)Senior VP & Chief Commercial Officer Compensation: $710kMr. Michael Rossi (Age 53)CEO, President & Director 1 recent tradesMr. Joris Wiel Jan Wilms (Age 50)Senior VP & COO Dr. Torben Lund-Hansen M.Sc. (Age 73)Ph.D., Senior VP & CTO Dr. Steen Lisby M.D. (Age 60)M.Sc., Senior VP & Chief Scientific Officer Compensation: $393.99kMs. Courtney DuganVice President of Investor RelationsDr. Vignesh Rajah M.B.A. (Age 59)MBBS, Senior VP & Chief Medical Officer Compensation: $406.27k More Insider Trading Tools from MarketBeat Related Companies CRMD Insider Trading NUVB Insider Trading QURE Insider Trading CRON Insider Trading SION Insider Trading ANAB Insider Trading DNA Insider Trading NAGE Insider Trading TNGX Insider Trading STOK Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Strategy Insiders Buy In While Analysts Predict Big UpsideThe Bottom Is in For These 3 Small-Cap Stocks Insiders Are Buying3 Catalysts Driving Plug Power’s Turnaround CaseInsider Selling Hits Market Leaders—Should You Be Worried?Insiders Spent Millions on These 3 Stocks Over the Past 2 Months This page (NASDAQ:YMAB) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredFormer CIA Officer Reveals How Gold Saved His Life This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | SponsoredShocked one of my clients with thisTrump Schedules Controversial 'Market Reset' for September 30 Behind closed doors, the White House has orde...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Y-mAbs Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Y-mAbs Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
